CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Hemcheck Sweden AB Company Snapshot
Hemcheck Sweden AB operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Hemcheck Sweden AB with three other pharmaceutical manufacturers in Europe: IGEA Pharma NV of NETHERLANDS (2017 sales of 6,844.67 Euros [US$7,977.47 ] ), Oncoarendi Therapeutics SA of POLAND (6,000.00 Polish New Zlotys [US$1,549.20 ] ), and Irlab Therapeutics Ab (109,000.00 Swedish Kronor [US$12,083.74 ] ).

Sales Analysis.
   
   
 
  Stock Performance Chart for Hemcheck Sweden AB
 
  Stock Data: Recent Stock Performance:
  Current Price (9/18/2020): 2.90
(Figures in Swedish Kronor)
1 Week -5.8%   13 Weeks -11.0%  
4 Weeks -28.4%   52 Weeks -3.3%  
 
Hemcheck Sweden AB Key Data:
  Ticker: HEMC Country: Sweden
  Exchanges: STO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2017 Sales 10,000
(Year Ending Jan 2018).
Employees: N/A
  Currency: Swedish Kronor Market Cap: 45,553,867
  Fiscal Yr Ends: December Shares Outstanding: 15,708,230
  Share Type: Aktie Closely Held Shares: N/A
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.